Minh Tam Truong, MBBS
Associate Professor
Boston University School of Medicine
Dept of Radiation Oncology

MBBS, University of New South Wales
favorite icon BMC

Dr. Truong is the Chair and Associate Professor of Radiation Oncology at BUSM and Chief of Radiation Oncology at Boston Medical Center. She received her medical degree from the University of New South Wales, Sydney Australia and completed her residency in Radiation Oncology at New York University Medical Center, her last year as chief resident. She is board certified in Radiation Oncology by the American Board of Radiology. Her specialties include the treatment of head and neck, skin and central nervous system malignancies, as well as benign diseases, including Airway Amyloidosis. Dr. Truong serves on a number of national committees including the Scientific Committee of the American Society for Therapeutic Radiation Oncology (ASTRO), on the head and neck and skin examination committee of the American Board of Radiology (ABR), and currently serves in NRG Oncology (National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)) as the Quality of Life Head and Neck Liaison. She is the Quality of Life Co-Chair on three national head and neck cancer multicenter trials conducted by the NRG Oncology group. She contributes her radiation expertise to the National Cancer Institute’s Adult Oncology Treatment editorial board. She also leads the Cyberknife Radiosurgery program for head and neck malignancies and brain tumors. She is actively involved in promoting clinical research activities at Boston Medical Center, and was awarded funding as Principal Investigator for an American Cancer Society/Boston University Institutional Grant for the investigation of novel function imaging in head and neck cancer using CT perfusion Imaging in Patients with Head and Neck Cancer undergoing Conformal Radiotherapy. Dr. Truong has also contributed to several Boston Medical Center funded research efforts including two U.S. Army Medical Research and Material Command Office Center of Excellence Program Projects and is a project principal investigator of a department of defense funded study investigating the role of stereotactic body radiotherapy for recurrent head and neck cancer.

Head and Neck Cancer
Skin Cancer, Cutaneous T Cell Lymphomas
Central Nervous System Malignancies
Radiotherapy for Airway Amyloidosis
Radiotherapy for Benign Diseases
Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
Cyberknife Radiosurgery
Intensity Modulated Radiotherapy
Image Guided Radiotherapy

Boston University School of Medicine
Radiation Oncology

Boston Medical Center
Radiation Oncology

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kirke DN, Qureshi MM, Kamran SC, Ezzat W, Jalisi S, Salama A, Everett PC, Truong MT. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis. Head Neck. 2018 Feb 08.View Related Profiles. PMID: 29417687.
  2. Singh B, Qureshi MM, Truong MT, Sahni D. Demographics and Outcomes of Stage I-II Merkel Cell Carcinoma Treated with Mohs Micrographic Surgery Compared with Wide Local Excision in the National Cancer Data Base. J Am Acad Dermatol. 2018 Feb 03.View Related Profiles. PMID: 29408552.
  3. Kamran SC, Qureshi MM, Jalisi S, Salama A, Grillone G, Truong MT. Primary surgery-versus primary radiation-based treatment for locally advanced oropharyngeal cancer. Laryngoscope. 2017 Oct 08.View Related Profiles. PMID: 28988426.
  4. Patel SA, Qureshi MM, Sahni D, Truong MT. Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following Resection: An Analysis of the National Cancer Database. JAMA Dermatol. 2017 Oct 01; 153(10):1007-1014.View Related Profiles. PMID: 28746702.
  5. Rubin SJ, Kirke DN, Ezzat WH, Truong MT, Salama AR, Jalisi S. Marital status as a predictor of survival in patients with human papilloma virus-positive oropharyngeal cancer. Am J Otolaryngol. 2017 Nov - Dec; 38(6):654-659.View Related Profiles. PMID: 28947344.
  6. Giacalone NJ, Qureshi MM, Mak KS, Kirke D, Patel SA, Shah BA, Salama AR, Jalisi S, Truong MT. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer. Laryngoscope. 2017 Aug 21.View Related Profiles. PMID: 28833217.
  7. Rubin SJ, Cohen MB, Kirke DN, Qureshi MM, Truong MT, Jalisi S. Comparison of facility type outcomes for oral cavity cancer: Analysis of the national cancer database. Laryngoscope. 2017 Nov; 127(11):2551-2557.View Related Profiles. PMID: 28671267; DOI: 10.1002/lary.26632;.
  8. Mak KS, Agarwal A, Qureshi MM, Truong MT. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database. Cancer Med. 2017 Jun; 6(6):1192-1200.View Related Profiles. PMID: 28440040.
  9. Shah BA, Qureshi MM, Logue JM, Cooley TP, Zaner KS, Jalisi S, Truong MT. Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy. Am J Otolaryngol. 2017 Jul - Aug; 38(4):456-461.View Related Profiles. PMID: 28427799; DOI: 10.1016/j.amjoto.2017.04.004;.
  10. Patel SA, Qureshi MM, Mak KS, Sahni D, Giacalone NJ, Ezzat W, Jalisi S, Truong MT. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection. Head Neck. 2017 Jul; 39(7):1371-1377.View Related Profiles. PMID: 28370725; DOI: 10.1002/hed.24776;.
Showing 10 of 52 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 52 publications over 13 distinct years, with a maximum of 10 publications in 2012


Students interested in oncology, radiation oncology, head and neck cancer, skin cancer, brain tumors, quality of life and outcomes research. Students interested in gaining exposure to novel technology for cancer therapy including Stereotactic Radiosurgery, Cyberknife Radiosurgery for brain tumors, recurrent head and neck cancer, metastatic disease.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Diversity Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')
  • Assistant
         Name: Monica Ryl
         Email: monica.ryl@bmc.org
         Phone: 6176387057

818 Harrison Ave
Boston MA 02118
Google Map

(617)630-7037 (fax)

Truong's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department